Saltoro Capital, LP Adaptive Biotechnologies Corp Transaction History

Saltoro Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $631,050 - $838,107	-21,021 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$32.22 - $44.59 $4.45 Million - $6.16 Million	-138,079 Reduced 86.79%	21,021 $859,000
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $5.41 Million - $9.83 Million	145,100 Added 1036.43%	159,100 $6.41 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $630,140 - $916,580	14,000 New	14,000 $828,000

204

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $973M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Saltoro Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Saltoro Capital, LP with notifications on news.